Keyphrases
Once-daily
100%
Real-world Practice
100%
Benign Prostatic Hyperplasia
100%
Alfuzosin
100%
Acute Urinary Retention
62%
International Prostate Symptom Score
62%
Bother
37%
Symptom Score
25%
Sexual Behavior
25%
Best Predictor
25%
4-point
25%
Lower Urinary Tract Symptoms
25%
PSA Value
25%
Beta-blockers
12%
Blood Pressure
12%
Dynamic Parameters
12%
Adverse Events
12%
Antihypertensive Drugs
12%
Vasodilatation
12%
Dizziness
12%
Patients at Risk
12%
Symptom Relief
12%
Baseline Variables
12%
General Practitioners
12%
Treatment Response
12%
Symptom Worsening
12%
Weighted Score
12%
Nocturia
12%
Intent-to-treat
12%
PSA Level
12%
Ejaculatory Dysfunction
12%
Symptom Bother
12%
High PSA
12%
Medicine and Dentistry
Prostate Hypertrophy
100%
Alfuzosin
100%
Symptom
62%
Urinary Retention
62%
International Prostate Symptom Score
62%
Lower Urinary Tract Symptom
25%
Deterioration
12%
Intention-to-Treat Analysis
12%
Blood Pressure
12%
Adverse Event
12%
Dizziness
12%
Antihypertensive Agent
12%
Vasodilatation
12%
General Practitioner
12%
Treatment Response
12%
Nocturia
12%
Ejaculatory Disorder
12%
Pharmacology, Toxicology and Pharmaceutical Science
Symptom
100%
Prostate Hypertrophy
100%
Alfuzosin
100%
Urine Retention
50%
Lower Urinary Tract Symptom
20%
Disease
10%
Deterioration
10%
Antihypertensive Agent
10%
Adverse Event
10%
Dizziness
10%
Nocturia
10%
Agricultural and Biological Sciences
Alfuzosin
100%
Urinary System
71%
Urinary Tract
28%
Europeans
14%
Blood Pressure
14%
Endpoints
14%
General Practitioner
14%